VITA THERAPEUTICS, INC.

Profile

Company Names

VITA THERAPEUTICS, INC.

Addresses

801 W. BALTIMORE STREET, SUITE 301, BALTIMORE, MD 21201

1812 ASHLAND AVENUE, UNIT 110, BALTIMORE, MD 21205

Phone Numbers

609-339-5126

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$62,892,990.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-10-11 
$30,892,998.00 
$30,892,998.00 
$0.00 
Equity 
2
2021-06-21 
$11,999,992.00 
$11,999,992.00 
$0.00 
Equity 
1
2021-01-12 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FAIZZAN 
 
AHMAD 
DIRECTOR
EVA 
 
CHIN 
DIRECTOR
DAVID 
 
CHURCHILL 
DIRECTOR
BROWN ADVISORY MANAGEMENT, LLC   |  THINGTECH LLC   |  BROWN ADVISORY INVESTORS SI INTERNATIONAL LLLP   |  BROWN ADVISORY GLOBAL MANAGERS, LLLP   |  BETA TECHNOLOGIES INC.   |  VITA THERAPEUTICS, INC.   |  ASHWOOD 2021 PRIVATE INVESTMENT I - AXIOM   |  ASHWOOD 2019 PRIVATE INVESTMENT II - ORKILA III   |  ASHWOOD 2020 PRIVATE INVESTMENT II - MC   |  ASHWOOD 2020 PRIVATE INVESTMENT I - ELEPHANT III   |  ASHWOOD 2021 PRIVATE INVESTMENT IV - BC III   |  ASHWOOD 2021 PRIVATE INVESTMENT VII - NATIONAL   |  ASHWOOD 2021 PRIVATE INVESTMENT VIII - NOSARA II   |  ASHWOOD 2021 PRIVATE INVESTMENT VI - ELEPHANT IV   |  ASHWOOD 2021 PRIVATE INVESTMENT V - ITC BROADBAND   |  ASHWOOD 2022 PRIVATE INVESTMENT I - WEF II   |  ASHWOOD 2022 PRIVATE INVESTMENT II - BC III A   |  ASHWOOD 2021 GLOBAL EQUITY I - BIOTECH   |  ASHWOOD 2020 PRIVATE INVESTMENT III - SWEETWATER   |  ASHWOOD 2021 PRIVATE INVESTMENT II - WAVECREST   |  ASHWOOD 2021 PRIVATE INVESTMENT III - MC II   |  ASHWOOD 2023 PRIVATE INVESTMENT II - VG   |  ASHWOOD 2020 GLOBAL EQUITY I - BLUE WATER SERIES   |  ASHWOOD 2022 PRIVATE INVESTMENT III - SQUADRA   |  ASHWOOD 2022 PRIVATE INVESTMENT IV - SRP   |  ASHWOOD 2023 PRIVATE INVESTMENT III - AR   |  ASHWOOD 2023 PRIVATE INVESTMENT IV - NT III   |  ASHWOOD 2023 PRIVATE INVESTMENT V - ELEPHANT IV A   |  ASHWOOD 2023 PRIVATE INVESTMENT VI - ELEPHANT V   |  ASHWOOD 2023 PRIVATE CREDIT II - SDOF III PARALLEL   |  ASHWOOD 2023 PRIVATE CREDIT II - SDOF III   |  ASHWOOD 2023 PRIVATE CREDIT I - SSO II   |  ASHWOOD 2023 PRIVATE INVESTMENT VII - KINETIC BROADBAND   |  ASHWOOD 2023 PRIVATE INVESTMENT VIII - CROCKETT   |  BRITTANY BROWN (ACAP SERIES)   |  BETA TECHNOLOGIES, INC.
VLAD 
 
CORIC 
DIRECTOR
DOUGLAS 
 
FALK 
EXECUTIVE OFFICER, DIRECTOR
PAT 
 
LAVECCHIA 
DIRECTOR
MARK 
 
NUTTALL 
DIRECTOR
JAMES 
 
PEYER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2022-10-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-21 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#